🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

There are about 2 weeks left to apply for this postdoctoral position to work on Shigella infection School of Immunology & Microbial Sciences! Contact me and apply if interested!

September 30, 2024 is the new deadline! Extension of DELGEME Plus calls for application for Msc class 2 in Antimicrobial Resistance until September 30, 2024. Please click on the link to see delgeme.org/delgemeplus/ca…

Non-typhoidal Salmonella (NTS) causes a significant global health burden, particularly in sub-Saharan Africa. Here's how a new Imperial College London human challenge study could pave the way to addressing this challenge. [1/6] 🧵

The African Postdoctoral Training Initiative #APTI is a postdoctoral training fellowship programme that is empowering early career African #scientists to tackle Africa's challenges in global health. Learn more👉shorturl.at/dglR9 #SDG3 #GlobalHealth Fogarty at NIH Gates Foundation Africa

PhD projects now open in Birmingham as part of MIBTP - funded and open to home and overseas students! Are you interested in bioprocesses, antimicrobial resistance, virulence, or biofilms?

Glad to have taken part in the WAAW National Scientific Symposium held on 18 & 19 November in Nairobi. I got to hear and see someone whose life was affected by AMR.

We are opening a call for applications 2025 – Creation of new junior research groups at the Institut Pasteur in Paris Institut Pasteur, since 1887 All details on our web site : research.pasteur.fr/en/call/call-f…

Investigators report broad dissemination of a highly drug-resistant Vibrio cholerae O1 El Tor strain across Africa. Read the full correspondence: nej.md/3Zxfwaf

We're inviting applications from researchers across Africa working in Antimicrobial Resistance (AMR), surveillance, or epidemiology and Individuals with basic knowledge in Molecular Biology for our upcoming hands-on training on AMR, Bacterial Genomics & Bioinformatics scheduled

Pls share: Postdoc position in microbiology with a focus on antibiotic heteroresistance

Happy to join colleagues from East Africa during the second workshop of the 2nd COHORT of Young East Africa Research Scientists (YEARS) Forum.

OPEN for Applications! African STARS Fellowship program - Spend 4 months with us at CERI or IPD to receive advanced training in genomics, diagnostics, and/or vaccine development. Unique opportunity to early-career scientist born in or based in Africa - starsfellows.africa

A new Gram-negative antibiotic from a novel chemical class! Gepotidacin is a triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by interaction with DNA gyrase and topoisomerase IV (similar target as quinolones, but different site). fiercepharma.com/pharma/gsk-ush…

The #GlobalAISummit2025 in Kigali was eye-opening! Powerful insights on AI’s role across sectors, need for infrastructure & access, and ethical use to prevent widening inequalities. Loved the idea: AI = African Intelligence As H.E. Paul Kagame said, Africa must lead, not follow!

This opportunity is for early-career researchers eager to develop their own groundbreaking contributions to human life, health, and wellbeing. It was shared on the Afredac Ubuntu Platform 4 days ago! Visit afredac.net to read more and check other opportunities!

Are you interested in a MSc in Bioinformatics of Infectious Diseases and Pathogen Genomics? This opportunity at Stellenbosch University is highly recommended— apply now if you’re interested. Deadline: 26 June 2025 More details below ⬇️

🚨 This is Big! New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority, 📖 Read the study 👇

🆕 Researchers at Cornell University identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes #typhoid. The likelihood of encountering rifampin-resistant typhoid cases is less than 1 in every 1,000 cases, according to the findings.

🌍A new study, led by the #MAAP research consortium, covering 14 African countries from 2016-2019, published PLOS Medicine, finds resistance to critical antibiotics used to treat severe bacterial infections is widespread and has significant variations. flemingfund.org/publications/a…

📢 #Kenya is introducing #typhoid conjugate vaccines (TCVs), launching a milestone campaign to protect 21M children from typhoid. Congratulations to the leaders in Kenya and the partners who made it happen! WHO African Region @Gavi PATH UNICEF Kenya Ministry of Health